TY - JOUR
T1 - Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis
AU - the Mechanical Thrombectomy in IE Investigators
AU - Cat-SCR Consortium
AU - Lapeña, Pau
AU - Urra, Xabier
AU - Llopis, Jaume
AU - Hernández-Meneses, Marta
AU - Cuervo, Guillermo
AU - Maisterra, Olga
AU - Escrihuela-Vidal, Francesc
AU - Prats-Sánchez, Luis
AU - Sáez, Carmen
AU - Olmos, Carmen
AU - Hernández-Fernández, Francisco
AU - Werner, Mariano
AU - Pérez de la Ossa, Natalia
AU - Quintana, Eduard
AU - Moreno, Asunción
AU - Chamorro, Angel
AU - Miró, José M.
AU - Cardona, Pere
AU - Quesada, Helena
AU - Lara, Blanca
AU - Paipa, Andrés
AU - Nuñez Guillen, Ana
AU - Barranco, Roger
AU - Aja, Lucia
AU - Mora, Paloma
AU - Chirife, Oscar
AU - Aixut, Sonia
AU - Angeles de Miquel, Maria
AU - Martínez-Yelamos, Toni
AU - Molina, Carlos
AU - Rubiera, Marta
AU - Pagola, Jorge
AU - Rodríguez-Luna, David
AU - Boned, Sandra
AU - Muchada, Marian
AU - Tomasello, Alejandro
AU - Ribó, Marc
AU - Piñana, Carlos
AU - Requena, Manuel
AU - Deck, Matías
AU - Garcia-Tornel, Alvaro
AU - Olivé, Marta
AU - Rodriguez, Noelia
AU - Juega, Jesus
AU - Chamorro, Ángel
AU - Amaro, Sergio
AU - Urra, Xabier
AU - Llull, Laura
AU - Renú, Arturo
AU - Rudiloso, Salvatore
N1 - Publisher Copyright:
© 2025 European Society of Clinical Microbiology and Infectious Diseases
PY - 2025
Y1 - 2025
N2 - Objectives: Acute ischaemic strokes (stroke) are frequent and severe extracardiac complications in infective endocarditis (IE). Because intravenous thrombolysis (i.v.-thrombolysis) is contraindicated, mechanical thrombectomy (thrombectomy) offers potential benefits. We aimed to compare thrombectomy efficacy and safety between IE-related and general stroke cases. Methods: Multicentre study of consecutive IE cases treated with thrombectomy at nine stroke centres in Spain from 2011 to 2022. Using propensity score matching, 50 IE cases were 1:4 matched with patients without IE stroke (n = 200). Efficacy was defined by successful recanalization rates (modified treatment in cerebral ischaemia scale ≥2 b), neurological improvement at 24 hours (decrease of National Institutes of Health Stroke Scale compared with baseline), and good neurological outcome rates at 3 months (modified Rankin scale ≤2). Safety was assessed by intracranial haemorrhage (IC-haemorrhage), symptomatic IC-haemorrhage, crude mortality, and stroke-related mortality. Results: Among 54 IE cases, 50 were matched with 200 controls. Successful recanalization was similarly achieved in both groups (76% vs. 83%). Median National Institutes of Health Stroke Scale at 24 hours was comparable, with analogous rates of neurological improvement (78% vs. 78%), and early dramatic response (48% vs. 46.5%). No differences were seen regarding IC-haemorrhage rates, except for when prior i.v.-thrombolysis was given. Although crude mortality was higher in the IE cohort, no differences were seen in stroke-related mortality (12% vs. 15%). At 3 months, modified Rankin scale scores of the two groups were superimposable. Discussion: Thrombectomy in IE is as effective and safe as in patients without IE, and prior i.v.-thrombolysis could decrease the procedural safety. Clinical practice guidelines may consider including the recommendation to perform thrombectomy alone in IE-related stroke.
AB - Objectives: Acute ischaemic strokes (stroke) are frequent and severe extracardiac complications in infective endocarditis (IE). Because intravenous thrombolysis (i.v.-thrombolysis) is contraindicated, mechanical thrombectomy (thrombectomy) offers potential benefits. We aimed to compare thrombectomy efficacy and safety between IE-related and general stroke cases. Methods: Multicentre study of consecutive IE cases treated with thrombectomy at nine stroke centres in Spain from 2011 to 2022. Using propensity score matching, 50 IE cases were 1:4 matched with patients without IE stroke (n = 200). Efficacy was defined by successful recanalization rates (modified treatment in cerebral ischaemia scale ≥2 b), neurological improvement at 24 hours (decrease of National Institutes of Health Stroke Scale compared with baseline), and good neurological outcome rates at 3 months (modified Rankin scale ≤2). Safety was assessed by intracranial haemorrhage (IC-haemorrhage), symptomatic IC-haemorrhage, crude mortality, and stroke-related mortality. Results: Among 54 IE cases, 50 were matched with 200 controls. Successful recanalization was similarly achieved in both groups (76% vs. 83%). Median National Institutes of Health Stroke Scale at 24 hours was comparable, with analogous rates of neurological improvement (78% vs. 78%), and early dramatic response (48% vs. 46.5%). No differences were seen regarding IC-haemorrhage rates, except for when prior i.v.-thrombolysis was given. Although crude mortality was higher in the IE cohort, no differences were seen in stroke-related mortality (12% vs. 15%). At 3 months, modified Rankin scale scores of the two groups were superimposable. Discussion: Thrombectomy in IE is as effective and safe as in patients without IE, and prior i.v.-thrombolysis could decrease the procedural safety. Clinical practice guidelines may consider including the recommendation to perform thrombectomy alone in IE-related stroke.
KW - Acute ischaemic stroke
KW - Cerebral embolism
KW - Endovascular therapy
KW - Infective endocarditis
KW - Mechanical thrombectomy
KW - Thrombolysis
UR - http://www.scopus.com/inward/record.url?scp=105000049519&partnerID=8YFLogxK
U2 - 10.1016/j.cmi.2025.02.008
DO - 10.1016/j.cmi.2025.02.008
M3 - Article
C2 - 39924109
AN - SCOPUS:105000049519
SN - 1198-743X
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
ER -